Clinical Trial Update: Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma [Phase 2]

View source ↗

Summary

Phase Ib/II study update evaluating fluzoparib in combination with dalpiciclib for locally advanced or metastatic sarcoma (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN